Artemether
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06697 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acquired angioedema | KG + DL |
| 2 | Plasmodium falciparum malaria | KG + DL |
| 3 | malaria | KG + DL |
| 4 | angioedema | KG + DL |
| 5 | hereditary angioedema | KG + DL |
| 6 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 7 | acute contagious conjunctivitis | KG + DL |
| 8 | scleroderma (disease) | KG + DL |
| 9 | conjunctivitis | KG + DL |
| 10 | renin-angiotensin-aldosterone system-blocker-induced angioedema | KG + DL |
| 11 | Legionnaires’ disease | KG + DL |
| 12 | rheumatoid arthritis | KG + DL |
| 13 | gout | KG + DL |
| 14 | pneumocystosis | KG + DL |
| 15 | HIV infectious disease | KG + DL |
| 16 | acute intermittent porphyria | KG + DL |
| 17 | brachydactyly-syndactyly syndrome | KG + DL |
| 18 | autoimmune hemolytic anemia | KG + DL |
| 19 | Pontiac fever | KG + DL |
| 20 | autosomal recessive familial Mediterranean fever | KG + DL |
| 21 | multidrug-resistant tuberculosis | KG + DL |
| 22 | diffuse cutaneous systemic sclerosis | KG + DL |
| 23 | complement component C1s deficiency | KG + DL |
| 24 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 25 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 26 | simian immunodeficiency virus infection | KG + DL |
| 27 | feline acquired immunodeficiency syndrome | KG + DL |
| 28 | limited systemic sclerosis | KG + DL |
| 29 | acquired aplastic anemia | KG + DL |
| 30 | amebic dysentery | KG + DL |
| 31 | disorder of GPI anchor biosynthesis | KG + DL |
| 32 | cold urticaria | KG + DL |
| 33 | Plasmodium vivax malaria | KG + DL |
| 34 | Smouldering systemic mastocytosis | KG + DL |
| 35 | allergic urticaria | KG + DL |
| 36 | collagenopathy | KG + DL |
| 37 | hemoglobinuria | KG + DL |
| 38 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 39 | systemic mastocytosis | KG + DL |
| 40 | dysentery | KG + DL |
| 41 | lymphocytic hypereosinophilic syndrome | KG + DL |
| 42 | inactive tuberculosis | KG + DL |
| 43 | tuberculosis, avian | KG + DL |
| 44 | tuberculoma | KG + DL |
| 45 | tuberculous ascites | KG + DL |
| 46 | Ehlers-Danlos syndrome, periodontal | KG + DL |
| 47 | bronchitis | KG + DL |
| 48 | tuberculosis, bovine | KG + DL |
| 49 | epulis | KG + DL |
| 50 | keratoconjunctivitis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.